Clindamycin Palmitate Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Clindamycin Palmitate Hydrochloride Injection (injection) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on Mar 26, 2026.

Shortage details

Status
To Be Discontinued
Company
Amneal Pharmaceuticals
Package NDC
53746-468-19
Dosage Form
Injection
Presentation
Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)
Initial Posting
Mar 26, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.